Arvinas Inc (ARVN)
25.86
+0.75
(+2.99%)
USD |
NASDAQ |
Nov 22, 16:00
25.88
+0.02
(+0.08%)
After-Hours: 20:00
Arvinas Enterprise Value: 655.92M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 655.92M |
| November 21, 2024 | 604.39M |
| November 20, 2024 | 438.10M |
| November 19, 2024 | 365.95M |
| November 18, 2024 | 472.46M |
| November 15, 2024 | 423.67M |
| November 14, 2024 | 591.33M |
| November 13, 2024 | 620.19M |
| November 12, 2024 | 686.84M |
| November 11, 2024 | 805.72M |
| November 08, 2024 | 743.87M |
| November 07, 2024 | 785.79M |
| November 06, 2024 | 802.28M |
| November 05, 2024 | 727.38M |
| November 04, 2024 | 720.51M |
| November 01, 2024 | 727.38M |
| October 31, 2024 | 695.09M |
| October 30, 2024 | 779.60M |
| October 29, 2024 | 768.61M |
| October 28, 2024 | 742.50M |
| October 25, 2024 | 660.04M |
| October 24, 2024 | 729.78M |
| October 23, 2024 | 700.92M |
| October 22, 2024 | 704.36M |
| October 21, 2024 | 648.71M |
| Date | Value |
|---|---|
| October 18, 2024 | 741.46M |
| October 17, 2024 | 736.65M |
| October 16, 2024 | 788.86M |
| October 15, 2024 | 658.33M |
| October 14, 2024 | 642.53M |
| October 11, 2024 | 674.13M |
| October 10, 2024 | 597.19M |
| October 09, 2024 | 596.50M |
| October 08, 2024 | 650.09M |
| October 07, 2024 | 616.42M |
| October 04, 2024 | 593.75M |
| October 03, 2024 | 560.78M |
| October 02, 2024 | 575.89M |
| October 01, 2024 | 588.26M |
| September 30, 2024 | 571.08M |
| September 27, 2024 | 470.35M |
| September 26, 2024 | 444.27M |
| September 25, 2024 | 396.21M |
| September 24, 2024 | 469.67M |
| September 23, 2024 | 434.66M |
| September 20, 2024 | 531.45M |
| September 19, 2024 | 529.39M |
| September 18, 2024 | 486.14M |
| September 17, 2024 | 510.17M |
| September 16, 2024 | 498.50M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-217.05M
Minimum
Oct 27 2023
4.699B
Maximum
Jul 29 2021
1.428B
Average
1.151B
Median
May 29 2024
Enterprise Value Benchmarks
| Pfizer Inc | 202.30B |
| NovaBay Pharmaceuticals Inc | 2.608M |
| Palatin Technologies Inc | 16.38M |
| iBio Inc | 14.05M |
| Theriva Biologics Inc | -12.68M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -49.20M |
| Revenue (Quarterly) | 102.40M |
| Total Expenses (Quarterly) | 162.70M |
| EPS Diluted (Quarterly) | -0.68 |
| Profit Margin (Quarterly) | -48.05% |
| Earnings Yield | -18.06% |
| Normalized Earnings Yield | -18.06 |